Jci_page_head_homepage_01 Jci_page_head_homepage_02
Mallika Ghosh, Hector Leonardo Aguila, Jason Michaud, Youxi Ai, Ming-Tao Wu, Annabrita Hemmes, Ari Ristimaki, Caiying Guo, Henry Furneaux, Timothy Hla
Published in Volume 119, Issue 12
J Clin Invest. 2009; 119(12):3530–3543 doi:10.1172/JCI38263
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 10
Binding and regulation of Mdm-2 by HuR in MEFs.

(A) Growth curve and (B) IB analysis of MEF cells isolated from Elavl1f/f and Elavl1f/f/RosaCre mice treated with different doses of 4HT for the indicated time periods (*P < 0.05; n = 3). For IB analysis, MEFs treated with 2.5 μM of 4HT are shown. (C) Ribonucleoprotein (RNP) complexes were immunoprecipitated from MEFs, using different doses of HuR-specific antibody or mouse IgG, and immunoprecipitated RNA was purified and analyzed for the level of Mdm2 transcript by q-RT-PCR. (*P < 0.05; n = 2). (D) Percentage of Mdm2 mRNA remaining was determined in Elavl1f/f and Elavl1Δ/Δ MEFs upon addition of Actinomycin D for the indicated time interval (n = 2). (E) IB analysis of Mdm-2 overexpression in MEFs transfected with pCMV6-Mdm-2 cDNA. (F) Growth curve analysis of Elavl1f/f/cre MEFs transfected with pCMV6-Mdm-2 or pCMV6 alone, in presence of 4HT or vehicle (ethanol, ETOH) for the indicated time intervals (*P < 0.05; n = 3).